RGBP
Price:
$0.0002
Market Cap:
$6.31K
Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.
Industry
Biotechnology
IPO Date
2014-10-06
Stock Exchange
OTC
Ticker
RGBP
According to Regen BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -98.16% compared to the average of -0.54 of the last 4 quarters.
The mean historical PE Ratio of Regen BioPharma, Inc. over the last ten years is 0.20. The current -0.01 PE Ratio has changed -601.54% with respect to the historical average. Over the past ten years (40 quarters), RGBP's PE Ratio was at its highest in in the September 2022 quarter at 24.21. The PE Ratio was at its lowest in in the March 2023 quarter at -14.69.
Average
0.20
Median
-0.34
Minimum
-6.79
Maximum
6.87
Discovering the peaks and valleys of Regen BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 140.46%
Maximum Annual PE Ratio = 6.87
Minimum Annual Increase = -8865.77%
Minimum Annual PE Ratio = -6.79
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.25 | -60.57% |
| 2024 | -0.63 | -110.14% |
| 2023 | 6.23 | -9.27% |
| 2022 | 6.87 | -201.28% |
| 2021 | -6.79 | -8865.77% |
| 2020 | 0.08 | -117.82% |
| 2019 | -0.43 | 140.46% |
| 2018 | -0.18 | -68.20% |
| 2017 | -0.57 | -75.73% |
| 2016 | -2.34 | -38.23% |
The current PE Ratio of Regen BioPharma, Inc. (RGBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.78
5-year avg
1.09
10-year avg
0.20
Regen BioPharma, Inc.’s PE Ratio is greater than Innovation Pharmaceuticals Inc. (-0.03), less than Viracta Therapeutics, Inc. (-0.01), greater than Wesana Health Holdings Inc. (-0.33), greater than RespireRx Pharmaceuticals Inc. (-0.10), greater than Actavia Life Sciences, Inc. (-0.07), less than Dental Patient Care America, Inc. (1.93), greater than ChitogenX Inc. (-0.23), greater than THC Farmaceuticals, Inc. (-4.54), greater than Levitee Labs Inc. (-0.03), greater than Nascent Biotech, Inc. (-0.03),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.03 | $103.67K | |
| -0.01 | $388.70K | |
| -0.33 | $341.00K | |
| -0.10 | $657.75K | |
| -0.07 | $385.91K | |
| 1.93 | $1.12M | |
| -0.23 | $627.63K | |
| -4.54 | $47.14K | |
| -0.03 | $369.15K | |
| -0.03 | $68.89K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regen BioPharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regen BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Regen BioPharma, Inc.'s PE Ratio?
How is the PE Ratio calculated for Regen BioPharma, Inc. (RGBP)?
What is the highest PE Ratio for Regen BioPharma, Inc. (RGBP)?
What is the 3-year average PE Ratio for Regen BioPharma, Inc. (RGBP)?
What is the 5-year average PE Ratio for Regen BioPharma, Inc. (RGBP)?
How does the current PE Ratio for Regen BioPharma, Inc. (RGBP) compare to its historical average?